Sarclisa (siltuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as a first-line treatment option ...

ImpriMed Unveils Cancer Treatment Prediction Technology at EHA-SfPM Meeting, Expands AI-Driven Precision Medicine Services ...

In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & Johnson), also carries a first-line indication for transplant-ineligible MM ...

A nurse practitioner discusses her role in caring for patients with multiple myeloma, and how advanced practice providers ...

A Boulder woman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being ...

Hashem was very clear about how you deal with Amalek, of which Hamas is a spiritual, if not physical descendant (which it likely is with Ishmael commingling with Amalek over the centuries).

19, 2024. After a long battle with Multiple Myeloma, he passed away at home, surrounded by his family. He was born on May 3, 1949, in Conway, Ark., to John Thurman, Sr. and Emma Lou Starkey Tyler.

The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...

Sanofi said the Food and Drug Administration has approved Sarclisa as a first line combined treatment option for adult patients with newly diagnosed multiple myeloma who aren't eligible for autologous ...

Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated ...